Adial Pharmaceuticals, Inc.ADILNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank30
3Y CAGR-26.9%
5Y CAGR-33.4%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
-26.9%/yr
vs -24.5%/yr prior
5Y CAGR
-33.4%/yr
Recent acceleration
Acceleration
-2.4pp
Decelerating
Percentile
P30
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.70 | -84.9% |
| 2024 | 4.62 | +611.2% |
| 2023 | 0.65 | -63.6% |
| 2022 | 1.78 | -87.5% |
| 2021 | 14.31 | +169.2% |
| 2020 | 5.32 | +59.8% |
| 2019 | 3.33 | -39.4% |
| 2018 | 5.49 | +124.7% |
| 2017 | -22.23 | +88.1% |
| 2016 | -186.98 | - |